Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ultraviolet light irradiation reduces human islet immunogenicity without altering islet function

P Y Benhamou1, E Stein, C Hober

  • 1Diabetes Research Center, UCLA School of Medicine, USA.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The health impact of smokeless tobacco products: a systematic review.

Harm reduction journal·2021
Same author

Hypes, hopes and translational challenges on the path to cures.

CellR4-- repair, replacement, regeneration, & reprogramming·2021
Same author

Identifying symptoms using the drawings of 4-7 year olds with cancer.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2018
Same author

Esophageal distensibility measurement: impact on clinical management and procedure length.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.

Osteoarthritis and cartilage·2016
Same author

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

Current molecular medicine·2015

Ultraviolet (UV)-B irradiation of human islets at 300 J/m2 effectively reduces immunogenicity without impairing viability or function. This finding supports UV-B therapy as a strategy to improve islet transplantation outcomes for diabetic patients.

Area of Science:

  • Immunology
  • Endocrinology
  • Transplantation Science

Background:

  • Allograft rejection is a primary barrier to successful islet transplantation for diabetes.
  • Reducing donor islet immunogenicity is crucial for improving transplant survival.
  • Animal studies suggest ultraviolet (UV)-B light can modulate immune responses and benefit allografts, but species-specific toxicity to beta-cells is a concern.

Purpose of the Study:

  • To determine the optimal in vitro UV-B dose for human islets that reduces immunogenicity while preserving viability and function.
  • To establish a safe and effective UV-B irradiation protocol for enhancing islet transplantation.

Main Methods:

  • Human islets were isolated and exposed to varying doses of UV-B irradiation (300-900 J/m2).
  • Islet viability and function were assessed using static incubation, perifusion tests for glucose-stimulated insulin release, and histology.

Related Experiment Videos

  • Immunogenicity was evaluated via in vitro mixed islet-lymphocyte cultures.
  • Functional assessment of transplanted islets was performed in athymic mice.

    • Main Results:

    • UV-B irradiation at 300 J/m2 did not impair insulin release in functional assays.
    • A dose of 500 J/m2 showed a minor decrease in stimulated insulin release in the perifusion system.
    • Higher doses (600 and 900 J/m2) significantly altered both basal and stimulated insulin release.
    • Islets irradiated at 300 J/m2 maintained insulin staining and responded to glucose challenge post-transplantation in mice.

    Conclusions:

    • UV-B irradiation at 300 J/m2 is a safe and effective dose for reducing human islet immunogenicity without compromising viability or function.
    • This dose represents a promising therapeutic window for enhancing islet transplantation outcomes.
    • Further research can explore the clinical application of UV-B pre-treatment for allogeneic islet grafts.